AnalystLens
Stocks
IDEXX LABORATORIES INC /DE
Other
Cash Flow
Proceeds from Debt
Search...
⌘K
Stocks
Sectors
Log in
Sign up
Income Statement
Balance Sheet
Cash Flow
Per Share
Back to IDXX
IDEXX LABORATORIES INC /DE Proceeds from Debt 2014-2015 | IDXX
Beta
No annual data available.
Proceeds from Debt History
Annual
Quarterly
Period
Value
Change · QoQ
Source
Q3 FY2015
$0
-100.0%
10-Q
Q2 FY2015
$100.1M
-33.3%
10-Q
Q1 FY2015
$150.0M
-25.0%
10-Q
Q3 FY2014
$200.0M
-
10-Q
All IDEXX LABORATORIES INC /DE (IDXX) Financial Metrics
Income Statement
Revenue
Cost of Revenue
Gross Profit
R&D
G&A
Sales & Marketing
Total OpEx
Operating Income
Interest Expense
Pre-tax Income
Income Tax
Net Income
Comprehensive Income
EPS (Basic)
EPS (Diluted)
Balance Sheet
Cash & ST Investments
Total Assets
Current Assets
Cash
Short-Term Investments
Receivables
Inventory
Prepaid & Other
PP&E
Goodwill
Intangibles
Other Non-current
Total Liabilities
Current Liabilities
Accounts Payable
Accrued Liabilities
Short-Term Debt
Deferred Revenue
Long-Term Debt
Other Non-current Liab.
Equity
Retained Earnings
Accumulated OCI
APIC
Treasury Stock
NCI
Total L&E
Shares Outstanding
Cash Flow
Operating Cash Flow
D&A
SBC
Deferred Tax
Investing Cash Flow
CapEx
Free Cash Flow
Acquisitions
Financing Cash Flow
Debt Issuance
Buybacks
Net Change in Cash
Per Share
EPS (Basic)
EPS (Diluted)
Shares Basic
Shares Diluted
Company:
IDEXX LABORATORIES INC /DE
Ticker:
IDXX
Sector:
Other
Industry:
In Vitro & In Vivo Diagnostic Substances
View company profile →